Structure of the human mTOR complex I and its implications for rapamycin inhibition.
暂无分享,去创建一个
D. Sabatini | T. Walz | C. Yip | K. Murata | Seong A. Kang | Kazuyoshi Murata | S. A. Kang | Thomas Walz
[1] B. L. Sibanda,et al. Crystal Structure of DNA-PKcs Reveals a Large Open-Ring Cradle Comprised of HEAT Repeats , 2009, Nature.
[2] J. Blenis,et al. Molecular mechanisms of mTOR-mediated translational control , 2009, Nature Reviews Molecular Cell Biology.
[3] D. Sabatini,et al. An ATP-competitive Mammalian Target of Rapamycin Inhibitor Reveals Rapamycin-resistant Functions of mTORC1* , 2009, Journal of Biological Chemistry.
[4] Robbie Loewith,et al. Active-Site Inhibitors of mTOR Target Rapamycin-Resistant Outputs of mTORC1 and mTORC2 , 2009, PLoS biology.
[5] Sang Gyun Kim,et al. Rapamycin differentially inhibits S6Ks and 4E-BP1 to mediate cell-type-specific repression of mRNA translation , 2008, Proceedings of the National Academy of Sciences.
[6] David M. Sabatini,et al. The Rag GTPases Bind Raptor and Mediate Amino Acid Signaling to mTORC1 , 2008, Science.
[7] Thomas Walz,et al. Negative Staining and Image Classification – Powerful Tools in Modern Electron Microscopy , 2004, Biological Procedures Online.
[8] Ernesto Arias-Palomo,et al. Structure of TOR and its complex with KOG1. , 2007, Molecular cell.
[9] David M Sabatini,et al. Defining the role of mTOR in cancer. , 2007, Cancer cell.
[10] R. Roth,et al. PRAS40 Regulates mTORC1 Kinase Activity by Functioning as a Direct Inhibitor of Substrate Binding* , 2007, Journal of Biological Chemistry.
[11] S. Carr,et al. PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase. , 2007, Molecular cell.
[12] J. Urano,et al. Point mutations in TOR confer Rheb-independent growth in fission yeast and nutrient-independent mammalian TOR signaling in mammalian cells , 2007, Proceedings of the National Academy of Sciences.
[13] Timothy J. Griffin,et al. Insulin signalling to mTOR mediated by the Akt/PKB substrate PRAS40 , 2007, Nature Cell Biology.
[14] Nikolaus Grigorieff,et al. FREALIGN: high-resolution refinement of single particle structures. , 2007, Journal of structural biology.
[15] D. Guertin,et al. Ablation in mice of the mTORC components raptor, rictor, or mLST8 reveals that mTORC2 is required for signaling to Akt-FOXO and PKCalpha, but not S6K1. , 2006, Developmental cell.
[16] T. Maeda,et al. Nutrient-dependent Multimerization of the Mammalian Target of Rapamycin through the N-terminal HEAT Repeat Region* , 2006, Journal of Biological Chemistry.
[17] J. Lawrence,et al. Activation of Mammalian Target of Rapamycin (mTOR) by Insulin Is Associated with Stimulation of 4EBP1 Binding to Dimeric mTOR Complex 1* , 2006, Journal of Biological Chemistry.
[18] L. Cantley,et al. Ras, PI(3)K and mTOR signalling controls tumour cell growth , 2006, Nature.
[19] Laurence H Pearl,et al. Three-dimensional structure of the human DNA-PKcs/Ku70/Ku80 complex assembled on DNA and its implications for DNA DSB repair. , 2006, Molecular cell.
[20] T. P. Neufeld,et al. Drosophila Target of Rapamycin Kinase Functions as a Multimer , 2006, Genetics.
[21] D. Sabatini,et al. Growing roles for the mTOR pathway. , 2005, Current opinion in cell biology.
[22] Joseph Avruch,et al. Rheb Binds and Regulates the mTOR Kinase , 2005, Current Biology.
[23] D. Guertin,et al. Phosphorylation and Regulation of Akt/PKB by the Rictor-mTOR Complex , 2005, Science.
[24] N. Sonenberg,et al. Regulation of cap-dependent translation by eIF4E inhibitory proteins , 2005, Nature.
[25] Conrad C. Huang,et al. UCSF Chimera—A visualization system for exploratory research and analysis , 2004, J. Comput. Chem..
[26] N. Grigorieff,et al. Accurate determination of local defocus and specimen tilt in electron microscopy. , 2003, Journal of structural biology.
[27] Paul Tempst,et al. GbetaL, a positive regulator of the rapamycin-sensitive pathway required for the nutrient-sensitive interaction between raptor and mTOR. , 2003, Molecular cell.
[28] D. Sabatini,et al. mTOR Interacts with Raptor to Form a Nutrient-Sensitive Complex that Signals to the Cell Growth Machinery , 2002, Cell.
[29] J. Avruch,et al. Raptor, a Binding Partner of Target of Rapamycin (TOR), Mediates TOR Action , 2002, Cell.
[30] W Chiu,et al. EMAN: semiautomated software for high-resolution single-particle reconstructions. , 1999, Journal of structural biology.
[31] S. Gygi,et al. Regulation of 4E-BP1 phosphorylation: a novel two-step mechanism. , 1999, Genes & development.
[32] J. M. Smith,et al. Ximdisp--A visualization tool to aid structure determination from electron microscope images. , 1999, Journal of structural biology.
[33] Stuart L. Schreiber,et al. Structure of the FKBP12-Rapamycin Complex Interacting with Binding Domain of Human FRAP , 1996, Science.
[34] R A Crowther,et al. MRC image processing programs. , 1996, Journal of structural biology.
[35] A Leith,et al. SPIDER and WEB: processing and visualization of images in 3D electron microscopy and related fields. , 1996, Journal of structural biology.
[36] S. Schreiber,et al. PIK-Related Kinases: DNA Repair, Recombination, and Cell Cycle Checkpoints , 1995, Science.
[37] S. Schreiber,et al. Identification of an 11-kDa FKBP12-rapamycin-binding domain within the 289-kDa FKBP12-rapamycin-associated protein and characterization of a critical serine residue. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[38] Paul Tempst,et al. RAFT1: A mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORs , 1994, Cell.
[39] S. Jackson,et al. The DNA-dependent protein kinase: Requirement for DNA ends and association with Ku antigen , 1993, Cell.